期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

无法手术局部晚期非小细胞肺癌的治疗 被引量：2

Regimens for inoperable locally advanced non-small cell lung cancer
原文传递
导出
摘要 同期放化疗是无法手术的局部晚期非小细胞肺癌（LA-NSCLC）患者的标准治疗方案.正电子放射断层造影术（PET）/CT及四维CT（4D-CT）的应用提高了放疗精确性并且减少了不良反应,诱导化疗和巩固化疗未能使患者生存获益,靶向治疗、免疫治疗将为LA-NSCLC患者的治疗带来前景. Concurrent chemoradiotherapy is the optimal regimen for patients with inoperable locally advanced non-small cell lung cancer （LA-NSCLC）. The application of new technologies such as positron emis- sion tomography （PET）/CT and four dimensional CT （4D-CT） enhances the accuracy of radiotherapy and decreases adverse reaction. Induction chemotherapy and consolidation chemotherapy do not show benefit to sur- vival. The targeted therapy and immunotherapy have the potential of improving the outcomes of inoperable LA-NSCLC.
作者 奚江 李文辉 王丽
机构地区 云南省肿瘤医院昆明医科大学第三附属医院放疗科
出处 《国际肿瘤学杂志》 CAS 2014年第4期279-282,共4页 Journal of International Oncology
关键词 癌 非小细胞肺 放射疗法 药物疗法 Carcinoma, non-small-cell lung Radiotherapy Drug therapy
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage 111 non-small-cell lung cancer[ J]. N Engl J Med, 1990, 323 (14) : 940-945.
  • 2Aup6rin A, Le P6choux C, Rolland E, et al. Meta-analysis of con- comitant versus sequential radiochemotherapy in locally advanced non- small-cell lung cancer [ J ]. J Clin Oncol, 2010, 28 ( 13 ) : 2181- 2190.
  • 3Machtay M, Bae K, Movsas B, et al. Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group[ J]. Int J Radiat Oncol Biol Phys, 2012, 82( 1 ) : 425-434.
  • 4Bradley JD, Bae K, Graham MV, et al. Primary analysis of the phase U component of a phase I / II dose intensification study using three- dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117 [J]. JClinOncol, 2010, 28(14): 2475-2480.
  • 5Harada H, Nishio M, Murakanfi H, et al. Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage 111 non-small-cell lung cancer[J]. Clin Lung Cancer, 2013, 14(4) : 440-445.
  • 6Cox JD. Are the results of RTOG 0617 mysterious? [J]. lnt J Radiat Oncol Biol Phys, 2012, 82(3) : 1042-1044.
  • 7Saunders M, Dische S, Barrett A, et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised muhicentre trial[ J]. The Lancet, 1997, 350(9072) : 161-165.
  • 8Belani CP, Wang W, Johnson DH, et al. Phase Ill study of the East- ern Cooperative Oncology Group ( ECOG 2597 ) : induction chemo- therapy followed hy either standard thoracic radiotherapy or hyperfrac- tionated accelerated radiotherapy for patients with unresectable stage IliA and B non-small-cell lung cancer[ J]. J Clin Oncol, 2005, 23 (16) : 3760-3767.
  • 9Din OS, Harden SV, Hudson E, et al. Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres [J]. Radiother Oncol, 2013, 109(1) : 8-12.
  • 10Bradley J, Bae K, Choi N, et al. A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosi- metric planning for non-small-cell lung cancer (NSCLC) : primary analysis of Radiation Therapy Oncology Group (RTOG) 0515 [ J]. Int J Radiat Oncol Biol Phys, 2012, 82( 1 ) : 435-441.

二级参考文献13

共引文献1

同被引文献27

  • 1Sonke J J,Belderbos J.Adaptive radiotherapy for lung cancer[J].Semin Radiat Oncol,2010,20(2):94-106.
  • 2Simone CB 2nd,Ly D,Dan TD,et al.Comparison of intensity-modulated radiotherapy,adaptive radiotherapy,proton radiotherapy,and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer[J].Radiother Oncol,2011,101 (3):376-382.
  • 3Worm ES,Hansen AT,Petersen JB,et al.Inter-and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and Lung[J].Acta Oncol,2010,49(7):1177-1183.
  • 4Cole AJ,O'Hare JM,McMahon SJ,et al.Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity,outcomes and dose escalation for radical lung cancer radiotherapy[J].Clin Oncol (R Coll Radiol),2014,26(3):142-150.
  • 5Giraud P,Antoine M,Larrouy A,et al.Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning[J].Int J Radiat Oncol Biol Phys,2000,48:1015-1024.
  • 6Osti MF,Agolli L,Valeriani M,et al.Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advancedstage non-small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2013,85(3):157-163.
  • 7Lavoie C,Higgins J,Bissonnette JP,et al.Volumetric image guidance using carina vs spine as registration landmarks for conventionally fractionated lung radiotherapy[J].Int J Radiat Oncol Biol Phys,2012,84(5):1086-1092.
  • 8Lim G,Bezjak A,Higgins J,et al.Tumor regression and positional changes in non-small cell lung cancer during radical radiotherapy[J].J Thorac Oncol,2011,6(3):531-536.
  • 9Tucker SL,Jin H,Wei X,et al.Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2010,77(3):691-698.
  • 10Zhang ZC,Xu J,Li BS,et al.Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung Cancer[J].Am J Clin Oncol,2010,33(3):271-275.

二级引证文献6

国际肿瘤学杂志
2014年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部